Assessment of CCR5i/maraviroc immunotherapy in combination with PD1 and MR-guided radiotherapy for treatment of pancreatic cancer

Lanfredini S., Hughes S., Thapa A., Bangs F., Morton J., Allen D., Kersemans V., Kinchesh P., Smart S., Elliot A., Thompson J., Hill M., Mukherjee S., O'Neill E.

DOI

10.1158/1538-7445.PANCA19-B30

Type

Conference paper

Publication Date

12/2019

Volume

79

Permalink Original publication